biological source
rabbit
antibody form
serum
antibody product type
primary antibodies
clone
polyclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable, western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
dry ice
Gene Information
human ... ITGAV(3685)
Immunogen
Epitope: cytoplasmic domain
Synthetic peptide corresponding to amino acids 1035-1048 of human integrin alphaV. This peptide sequence is absolutely conserved in the mouse integrin alphaV sequence.
Application
Anti-Integrin αV Antibody, cytoplasmic domain detects level of Integrin αV & has been published & validated for use in ELISA & WB.
ELISA: 1:500 (direct)
Western Blot: 1:500. Antibody detects a non-reducible 155 kDa band corresponding to integrin alphaV.
Optimal dilutions must be determined by the end user.
Western Blot: 1:500. Antibody detects a non-reducible 155 kDa band corresponding to integrin alphaV.
Optimal dilutions must be determined by the end user.
Research Category
Cell Structure
Cell Structure
Research Sub Category
Integrins
Integrins
Biochem/physiol Actions
Integrin alphaV
Physical form
Whole rabbit serum. Liquid containing no preservative
Preparation Note
Maintain at -20°C in undiluted aliquots for up to 12 months from date of receipt. Avoid repeated freeze/thaw cycles.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Still not finding the right product?
试用我们的 产品选型工具 工具缩小选择范围
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.
Beauvais, DM; Ell, BJ; McWhorter, AR; Rapraeger, AC
The Journal of Experimental Medicine null
Qi Cui et al.
Nature communications, 7, 10637-10637 (2016-02-04)
Glioblastomas have been proposed to be maintained by highly tumorigenic glioblastoma stem cells (GSCs) that are resistant to current therapy. Therefore, targeting GSCs is critical for developing effective therapies for glioblastoma. In this study, we identify the regulatory cascade of
Laura di Blasio et al.
Journal of cell science, 128(5), 863-877 (2015-01-16)
Non-amoeboid cell migration is characterised by dynamic competition among multiple protrusions to establish new adhesion sites at the cell's leading edge. However, the mechanisms that regulate the decision to disassemble or to grow nascent adhesions are not fully understood. Here